India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
State Ba 259.95 0.35
Tata Mot 170.55 2.43
Icici Ba 327.00 3.84
Axis Ban 562.00 0.04
I T C Lt 288.25 0.07
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Lupin Limited
Lupin Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
Market Lot: 1Face Value: 2ISIN Demat: INE326A01037
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
22-Oct-2018       Lupin announces positive CHMP opinion for NaMuscla IRIS
19-Oct-2018       Lupin's Pithampur unit-3 inspected by USFDA IRIS
16-Oct-2018       Lupin receives tentative approval for generic Lurasidone HCl tablets IRIS
10-Oct-2018       Lupin launches generic Clobetasol propionate ointment in US IRIS
04-Oct-2018       Lupin launches generic Potassium Chloride oral solution IRIS
01-Oct-2018       Lupin, Lilly partner for improved access to diabetes treatment in India IRIS
14-Sep-2018       Lupin's Nagpur facility inspection by USFDA concluded with no observation IRIS
13-Sep-2018       Lupin receives approval for generic Atovaquone oral solution IRIS
04-Sep-2018       Lupin's Tarapur API manufacturing facility inspected by USFDA IRIS
03-Sep-2018       Lupin gets USFDA's nod for generic Potassium Cl solution IRIS
28-Aug-2018       Lupin receives USFDA approval for generic Gabapentin tablets IRIS
27-Aug-2018       Lupin launches generic contraceptive drug in United States IRIS
24-Aug-2018       Lupin receives EIR from USFDA for Nagpur facility IRIS
24-Aug-2018       Lupin receives EIR from USFDA for Nagpur facility IRIS
23-Aug-2018       Lupin enters into dermatology segment in Brazil IRIS
22-Aug-2018       Lupin gets tentative USFDA nod for generic Nudovra IRIS
21-Aug-2018       Lupin launches generic Clobetasol propionate cream in US IRIS
21-Aug-2018       Lupin receives USFDA nod for generic Hydrocortisone Butyrate lotion IRIS
30-Jul-2018       Lupin's Mandideep facility gets approval from EDQM IRIS
27-Jul-2018       Lupin launches generic Desoximetasone topical spray IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited